[144] Confluent, Inc. SEC Filing

Rhea-AI Filing Summary

Confluent, Inc. (CFLT) filed a Form 144 reporting a proposed sale of 5,000 common shares by a person for whose account the securities are to be sold. The shares were granted as restricted stock units acquired on 05/20/2024 and the seller plans to execute the sale approximately on 09/08/2025 through Morgan Stanley Smith Barney LLC. The filing reports an aggregate market value of $96,700 for the 5,000 shares and shows 291,931,187 shares outstanding.

The notice also discloses a prior sale by the same person: 26,097 common shares sold on 08/20/2025 for gross proceeds of $443,909.97. The filer affirms they have no undisclosed material adverse information and cites Rule 144/10b5-1 representations as applicable.

Positive

• Clear disclosure of the proposed sale details (shares, value, broker and planned sale date) consistent with Rule 144 requirements
• Prior sale disclosed (26,097 shares on 08/20/2025 for $443,909.97), supporting transparency about recent insider transactions

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; small block relative to outstanding shares, limited market impact.

The Form 144 documents a planned sale of 5,000 shares (RSU-derived) with an indicated market value of $96,700 and discloses a recent sale of 26,097 shares for $443,909.97. Relative to the company's reported 291.9 million shares outstanding, these transactions represent a de minimis portion of float and are standard compliance activity under Rule 144. From a markets perspective, the sizes disclosed are unlikely to move the stock price materially but are relevant for transparency around insider liquidity.

Corporate Governance Expert

TL;DR: Filing reflects compliance with disclosure rules; includes required attestations about material non-public information.

The filing shows the seller affirming absence of undisclosed material adverse information and references potential 10b5-1 plan reliance. Proper disclosure of acquisition date (05/20/2024) and brokerage details supports good governance and insider trading transparency. There is no indication of unusual timing or large, concentrated disposals that would raise immediate governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	96700.00	291931187	09/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2024	Restricted Stock Units	Issuer			5000	05/20/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROHAN SIVARAM 899 W. EVELYN AVENUE MOUNTAIN VIEW CA 94041	Common	08/20/2025	26097	443909.97

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Confluent's (CFLT) Form 144 disclose about the proposed sale?

The notice reports a proposed sale of 5,000 common shares (RSU-derived) with an aggregate market value of $96,700, to be sold via Morgan Stanley on or about 09/08/2025.

When were the shares being sold by the filer acquired?

The 5,000 shares were acquired as restricted stock units on 05/20/2024.

Has the filer sold any Confluent shares recently?

Yes. The filing discloses a prior sale of 26,097 common shares on 08/20/2025 for gross proceeds of $443,909.97.

How large is the proposed sale relative to Confluent's outstanding shares?

The filing lists 291,931,187 shares outstanding; the proposed sale of 5,000 shares is a very small fraction of that total.

Does the filer state they possess any material non-public information?

The filer represents by signature that they do not know any material adverse information